CCR6 and Alzheimer disease: Dysregulation of the immune system has also been reported in the triple transgenic Alzheimer’s disease (3xTg-AD) mouse model of AD [20], including increased lymphocyte chemotaxis [21] and increased C-C chemokine receptor 6 (CCR6) expression outside of the CNS [22].